Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...
GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...
Canada’s panel of vaccine advisers has strongly recommended the new vaccines targeting the KP.2 strain, part of the ...
Anti-vaccine activist and former presidential candidate Robert F. Kennedy Jr., who’s been promised a prominent health care ...
Moderna said on Friday that Canada’s health regulator has approved its vaccine for respiratory syncytial virus (RSV) in adults 60 years and older, making it the country’s first authorized ...
Health officials say eligible residents can receive the COVID-19 vaccine at the same time as or at any time before or after ...
An initial 899,000 vaccine doses have been allocated for nine countries across Africa that have been hit hard by the current mpox surge, the WHO and other health organizations say.
Starting November 4, doses of the RSV immunization will also be available for infants and high-risk children up to 24 months ...
GlaxoSmithKline (GSK) has received approval for its vaccine, AREXVY, in Canada to prevent lower respiratory tract disease ...
The Alberta government is permanently cutting off the flow of publicly funded vaccines to community medical clinics, save a ...